GL1X · GenesisL1 explorer

UniProt S5ME50

RNA-directed RNA polymerase catalytic subunit (S5ME50)

RNA-directed RNA polymerase catalytic subunit (UniProt S5ME50): 9 experimental structures on GenesisL1, 3 ligands bound, 152 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
S5ME50
Protein
RNA-directed RNA polymerase catalytic subunit
Experimental structures
9
Predicted models
0
Ligands
3
Pockets
152 · 9 records with a druggable one

Structures

9 records of S5ME50 in the MolNFT archive: 9 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
8PNPInfluenza A/H7N9 polymerase in pre-initiation state with continuous Pol II pS5 CTD peptide mimic…electron microscopyB—18 (best 0.87)
8PNQInfluenza A/H7N9 polymerase in elongation state with continuous Pol II pS5 CTD peptide mimic bound…electron microscopyB2KH, MG20 (best 0.89)
8R3KInfluenza A/H7N9 polymerase in self-stalled pre-termination state, with Pol II pS5 CTD peptide…electron microscopyBPOP, MG19 (best 0.90)
8R3LInfluenza A/H7N9 polymerase in pre-initiation state, intermediate conformation (I) with PB2-C(I)…electron microscopyB—14 (best 0.85)
8RMPInfluenza polymerase A/H7N9-4M (ENDO(R) | Core1)electron microscopyBMG18 (best 0.79)
8RMQInfluenza polymerase A/H7N9-4M (ENDO(R) | Core2)electron microscopyBMG18 (best 0.82)
8RMRInfluenza polymerase A/H7N9-4M replication complex, an asymmetric polymerase dimer bound to human…electron microscopyB, EMG15 (best 0.85)
8RMSInfluenza polymerase A/H7N9-4M replicase minus 627(R) (from "Influenza polymerase A/H7N9-4M…electron microscopyBMG16 (best 0.85)
8RN0Influenza polymerase A/H7N9-4M encapsidase plus 627(R) / human ANP32A (from "Influenza polymerase…electron microscopyE—14 (best 0.81)

Ligands

  • MG · Magnesium ion · in 6 records
  • 2KH · 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]amino}phosphoryl]uridine · in 1 record
  • POP · Pyrophosphate 2- · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.